Empagliflozin vs Erlotinib

Empagliflozin vs Erlotinib: Overview

This comparison examines the pharmacological differences between Empagliflozin and Erlotinib.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Erlotinib — 36 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Erlotinib — C22H23N3O4.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Erlotinib — 393.4380 g/mol.

Type: Empagliflozin — Small molecule; Erlotinib — Small molecule.